Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis
- PMID: 25844170
- PMCID: PMC4380908
- DOI: 10.1002/sm2.53
Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis
Abstract
Introduction: The Female Sexual Distress Scale-Revised (FSDS-R) was created and validated to assess distress associated with impaired sexual function, but it is lengthy for use in clinical practice and research when assessing sexual function is not a primary objective.
Aim: The study aims to evaluate whether a single item from the FSDS-R could be identified to use to screen midlife women for bothersome diminution in sexual function based on three criteria: (i) highly correlated with total scores; (ii) correlated with commonly assessed domains of female sexual functioning; and (iii) able to differentiate between women reporting high and low sexual concerns during the prior month.
Methods: Data from 93 midlife women were collected by the Menopause Strategies Finding Lasting Answers to Symptoms and Health (MsFLASH) research network.
Main outcome measures: Women completed the FSDS-R, Female Sexual Function Index (FSFI), and Menopausal Quality of Life Scale (MENQOL). Those who reported a change in the past month on the MENQOL sexual were categorized into a high sexual concerns group, while all others were categorized into a low sexual concerns group.
Results: Women were an average of 54.6 years old (SD 3.1) and mostly Caucasian (77.4%), college educated (60.2%), married/living as married (64.5%), and postmenopausal (79.6%). The FSDS-R item number 1 "Distressed about sex life" was: (i) highly correlated with FSDS-R total scores (r = 0.90); (ii) moderately correlated with FSFI total scores (r = -0.38) and FSFI desire (r = -0.37) and satisfaction domains (r = -0.40); and (iii) showed one of the largest mean differences between high and low sexual concerns groups (P < 0.001). Other FSDS-R items met one or two, but not all three of the prespecified criteria (i, ii, iii).
Conclusions: A single FSDS-R item may be a useful screening tool to quickly identify midlife women with sexually related distress when it is not feasible to administer the entire scale, though further validation is warranted. Carpenter JS, Reed SD, Guthrie KA, Larson JC, Newton KM, Lau RJ, Learman LA, and Shifren JL. Using an FSDS-R item to screen for sexually related distress: A MsFLASH analysis. Sex Med 2015;3:7-13.
Keywords: Adult; Female; Female Sexual Distress Scale Revised; Menopause; Quality of Life; Sexual Behavior.
Similar articles
-
Psychometric properties of the Iranian version of the female sexual distress scale-revised in women.J Sex Med. 2014 Apr;11(4):995-1004. doi: 10.1111/jsm.12449. Epub 2014 Feb 12. J Sex Med. 2014. PMID: 24641598
-
Toward a better measure of midlife sexual function: pooled analyses in nearly 1,000 women participating in MsFLASH randomized trials.Menopause. 2022 Jan 31;29(4):397-407. doi: 10.1097/GME.0000000000001940. Menopause. 2022. PMID: 35102098 Free PMC article.
-
Convergent-Divergent Validity and Correlates of the Day-to-Day Impact of Vaginal Aging Domain Scales in the MsFLASH Vaginal Health Trial.J Sex Med. 2020 Jan;17(1):117-125. doi: 10.1016/j.jsxm.2019.10.010. Epub 2019 Dec 4. J Sex Med. 2020. PMID: 31812686 Free PMC article. Clinical Trial.
-
Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder.J Sex Med. 2008 Feb;5(2):357-64. doi: 10.1111/j.1743-6109.2007.00672.x. Epub 2007 Nov 27. J Sex Med. 2008. PMID: 18042215
-
FDA Decisions on Measures of Hypoactive Sexual Desire Disorder in Women: A History, With Grounds to Consider Clinical Judgment.Sex Med Rev. 2021 Apr;9(2):186-193. doi: 10.1016/j.sxmr.2020.12.001. Epub 2021 Jan 27. Sex Med Rev. 2021. PMID: 33516742 Review.
Cited by
-
Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial.JAMA Intern Med. 2018 May 1;178(5):681-690. doi: 10.1001/jamainternmed.2018.0116. JAMA Intern Med. 2018. PMID: 29554173 Free PMC article. Clinical Trial.
-
Sexual experiences of postmenopausal women in China: a qualitative study.Sex Med. 2023 Dec 4;11(6):qfad062. doi: 10.1093/sexmed/qfad062. eCollection 2023 Dec. Sex Med. 2023. PMID: 38058407 Free PMC article.
-
Actual and Desired Masturbation Frequency, Sexual Distress, and Their Correlates.Arch Sex Behav. 2023 Oct;52(7):3155-3170. doi: 10.1007/s10508-023-02641-3. Epub 2023 Jun 26. Arch Sex Behav. 2023. PMID: 37365448
-
Sexual Dysfunction in Alopecia Areata: A Systematic Review.J Clin Med. 2025 Apr 10;14(8):2602. doi: 10.3390/jcm14082602. J Clin Med. 2025. PMID: 40283432 Free PMC article. Review.
-
Lights on MsFLASH: a review of contributions.Menopause. 2020 Apr;27(4):473-484. doi: 10.1097/GME.0000000000001461. Menopause. 2020. PMID: 31977667 Free PMC article. Review.
References
-
- North American Menopause Society (NAMS) Menopause practice: A clinician's guide. 4th edition. Mayfield Heights, OH: NAMS; 2010. Chapter 4: clinical issues; p. 266 pp.
-
- Shifren JL, Johannes CB, Monz BU, Russo PA, Bennett L, Rosen R. Help-seeking behavior of women with self-reported distressing sexual problems. J Womens Health (Larchmt) 2009;18:461–468. - PubMed
-
- Latif EZ, Diamond MP. Arriving at the diagnosis of female sexual dysfunction. Fertil Steril. 2013;100:898–904. - PubMed
-
- Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191–208. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous